313 related articles for article (PubMed ID: 15831703)
1. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
Cooperman SS; Meyron-Holtz EG; Olivierre-Wilson H; Ghosh MC; McConnell JP; Rouault TA
Blood; 2005 Aug; 106(3):1084-91. PubMed ID: 15831703
[TBL] [Abstract][Full Text] [Related]
2. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development.
Smith SR; Ghosh MC; Ollivierre-Wilson H; Hang Tong W; Rouault TA
Blood Cells Mol Dis; 2006; 36(2):283-7. PubMed ID: 16480904
[TBL] [Abstract][Full Text] [Related]
3. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
Ghosh MC; Tong WH; Zhang D; Ollivierre-Wilson H; Singh A; Krishna MC; Mitchell JB; Rouault TA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):12028-33. PubMed ID: 18685102
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
Holme SA; Worwood M; Anstey AV; Elder GH; Badminton MN
Blood; 2007 Dec; 110(12):4108-10. PubMed ID: 17804693
[TBL] [Abstract][Full Text] [Related]
5. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2).
Galy B; Ferring D; Minana B; Bell O; Janser HG; Muckenthaler M; Schümann K; Hentze MW
Blood; 2005 Oct; 106(7):2580-9. PubMed ID: 15956281
[TBL] [Abstract][Full Text] [Related]
6. Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments.
Zumbrennen-Bullough KB; Becker L; Garrett L; Hölter SM; Calzada-Wack J; Mossbrugger I; Quintanilla-Fend L; Racz I; Rathkolb B; Klopstock T; Wurst W; Zimmer A; Wolf E; Fuchs H; Gailus-Durner V; de Angelis MH; Romney SJ; Leibold EA
PLoS One; 2014; 9(6):e98072. PubMed ID: 24896637
[TBL] [Abstract][Full Text] [Related]
7. Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Barman-Aksözen J; Halloy F; Iyer PS; Schümperli D; Minder AE; Hall J; Minder EI; Schneider-Yin X
Mol Genet Metab; 2019 Nov; 128(3):304-308. PubMed ID: 31076252
[TBL] [Abstract][Full Text] [Related]
8. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies.
Smith SR; Cooperman S; Lavaute T; Tresser N; Ghosh M; Meyron-Holtz E; Land W; Ollivierre H; Jortner B; Switzer R; Messing A; Rouault TA
Ann N Y Acad Sci; 2004 Mar; 1012():65-83. PubMed ID: 15105256
[TBL] [Abstract][Full Text] [Related]
9. Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.
Ghosh MC; Zhang DL; Rouault TA
Neurobiol Dis; 2015 Sep; 81():66-75. PubMed ID: 25771171
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria.
Troadec MB; Warner D; Wallace J; Thomas K; Spangrude GJ; Phillips J; Khalimonchuk O; Paw BH; Ward DM; Kaplan J
Blood; 2011 May; 117(20):5494-502. PubMed ID: 21310927
[TBL] [Abstract][Full Text] [Related]
11. The IRP/IRE system in vivo: insights from mouse models.
Wilkinson N; Pantopoulos K
Front Pharmacol; 2014; 5():176. PubMed ID: 25120486
[TBL] [Abstract][Full Text] [Related]
12. Regulation of expression of ferritin H-chain and transferrin receptor by protoporphyrin IX.
Coccia EM; Perrotti E; Stellacci E; Orsatti R; Del Russo N; Marziali G; Testa U; Battistini A
Eur J Biochem; 1997 Dec; 250(3):764-72. PubMed ID: 9461300
[TBL] [Abstract][Full Text] [Related]
13. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo.
Meyron-Holtz EG; Ghosh MC; Rouault TA
Science; 2004 Dec; 306(5704):2087-90. PubMed ID: 15604406
[TBL] [Abstract][Full Text] [Related]
14. [The role of iron regulatory proteins (IRPs) in the regulation of systemic iron homeostasis: lessons from studies on IRP1 and IRP2 knock out mice].
Lipiński P; Starzyński RR
Postepy Hig Med Dosw (Online); 2006; 60():322-30. PubMed ID: 16819431
[TBL] [Abstract][Full Text] [Related]
15. Serum transferrin receptor.
Skikne BS
Am J Hematol; 2008 Nov; 83(11):872-5. PubMed ID: 18821709
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
17. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.
Beguin Y
Clin Chim Acta; 2003 Mar; 329(1-2):9-22. PubMed ID: 12589962
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
Lyoumi S; Abitbol M; Andrieu V; Henin D; Robert E; Schmitt C; Gouya L; de Verneuil H; Deybach JC; Montagutelli X; Beaumont C; Puy H
Blood; 2007 Jan; 109(2):811-8. PubMed ID: 17003376
[TBL] [Abstract][Full Text] [Related]
19. Mammalian iron metabolism and its control by iron regulatory proteins.
Anderson CP; Shen M; Eisenstein RS; Leibold EA
Biochim Biophys Acta; 2012 Sep; 1823(9):1468-83. PubMed ID: 22610083
[TBL] [Abstract][Full Text] [Related]
20. [Effects of different zinc nutritional status on iron metabolism in rats].
Yang L; Wang C; Xiao F
Wei Sheng Yan Jiu; 2013 Jul; 42(4):647-51. PubMed ID: 24024381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
